Advanced Diagnostic Systems enlists Samsung for Asian sales of BI (breast imaging) system:
This article was originally published in Clinica
Preston, Washington-based Advanced Diagnostic Systems (ADI) has agreed that Korea's Samsung Corp will distribute its Avera breast imaging system in Asia. Samsung will buy at least 100 systems, which incorporate ADI's proprietary diffractive imaging energy technology, over a four-year period. The technology enables the provision of highly detailed images of the breast without the use of radiation or painful compression. Samsung will take its first deliveries in 2002, initially targeting medical institutions in Korea. ADI profiled the system at this year's Radiological Society of North America annual meeting.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.